Rayonier Advanced Materials (RYAM) announced it has raised EUR67M in green capital. The financing includes EUR37M in secured term loans from French banks Credit Lyonnais, Arkea Banque, and BNP Paribas at an initial floating rate of approximately 5%, maturing in seven years. An additional EUR30M in preferred equity will be provided by Swen Capital Partners through its strategy SWEN Impact Fund for Transition 3 for a 20% stake in the newly formed subsidiary, RYAM BioNova S.A.S. SWEN’s investment in BioNova reflects a valuation of greater than $160M for the new entity. Proceeds from the capital raise will be used to invest in projects to grow BioNova including a second-generation bioethanol plant and a prebiotics project. “The formation of BioNova and this latest round of financing are pivotal in our strategic push into biomaterials,” said De Lyle Bloomquist, President and CEO of RYAM. “With this green capital, we are poised to drive over $40M in EBITDA from these initiatives in 2027, underscoring our commitment to growth and sustainability.”
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter